跳至主要内容
临床试验/NCT00449423
NCT00449423终止2 期

Metabolic Modulation as Treatment in Acute Heart Failure

University of Aarhus2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2007年3月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
32
试验地点
2
主要终点
pulmonary Wedge Pressure

研究概览

简要总结

The primary objective of this study is to evaluate whether metabolic modulation improves hemodynamics and outcome in acute heart failure

详细描述

Acute heart failure is a serious disease that despite modern therapies carries a high mortality. Inotropic drugs improve patient status but yield a higher risk of death. Previous studies have shown that myocardial contractility improves when glucose fermentation is up regulated and decreases when Free Fatty Acids are high. In a placebo-controlled design we wish to shift myocardial substrate metabolism towards increased glucose uptake and utilization and measure hemodynamics and biochemical markers of metabolism and prognosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute heart failure
  • NYHA class III - IV.
  • ejection fraction <35

排除标准

  • Age <18 år or >85 år,
  • renal failure
  • recently developed brady- or tachy-arrythmias
  • Serious infection
  • Heart failure due to restrictive or hypertrophic cardiomyopathy or stenotic valvular heart disease
  • Recent Myocardial infarction (<6 Weeks)
  • Pulmonary Wedge pressure >30 mm Hg
  • diabetes mellitus treated with insulin
  • peptic ulcer
  • pregnancy

结局指标

主要结局

pulmonary Wedge Pressure

Ejection fraction

Cardiac index

次要结局

  • myocardial glucose- and Free Fatty Acid-extraction
  • cardiac output
  • Regional left ventricle function
  • outcome day 6 and 30

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Metabolic Modulation as Treatment in Acute Heart... | 临床试验